Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 29, 2026 06:30 ET | Source: Agios Pharmaceuticals, Inc.

Agios Reports First Quarter 2026 Financial Results and Provides Business Update

Agios announces first quarter 2026 financial results and provides business update.
April 28, 2026 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026

CORAL GABLES, Fla., April 28, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...
April 28, 2026 04:06 ET | Source: Research and Markets

KCNQ2 Developmental and Epileptic Encephalopathy Market Research Report 2025-2035, Competitive Analysis of Biohaven, Xenon Pharma, Lundbeck, Praxis Precision Medicines, NeuShen Therapeutics

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "KCNQ2 Developmental and Epileptic Encephalopathy Market - A Global and Regional Analysis: Focus on Country and Region, 2025-2035" report has been...
April 23, 2026 10:35 ET | Source: Foundation for Sarcoidosis Research

FSR, in Partnership with ATS, Welcomes Dr. Matt Craig to Drive Strategic Research Initiatives

FSR and ATS are pleased to welcome joint new hire John Matthew “Matt” Craig, PhD.
April 23, 2026 04:20 ET | Source: Research and Markets

Renal Tubular Acidosis Market Research and Global Long-term Forecast Report 2025-2035 Featuring Prominent Players - Advicenne and Mission Pharmacal Company

Dublin, April 23, 2026 (GLOBE NEWSWIRE) -- The "Renal Tubular Acidosis Market - A Global and Regional Analysis: Focus on Country and Regional Analysis, 2025-2035" report has been added to ...
April 23, 2026 04:06 ET | Source: Research and Markets

Tuberous Sclerosis Complex Market Research and Global Long-term Forecast Report 2026-2035 Featuring Prominent Players - Novartis, Jazz Pharmaceuticals, Nobelpharma America

Dublin, April 23, 2026 (GLOBE NEWSWIRE) -- The "Tuberous Sclerosis Complex Market - A Global and Regional Analysis: Focus on Country and Regional Analysis, 2025-2035" report has been added to ...
April 20, 2026 07:00 ET | Source: Soleo Health Holdings, Inc.

Soleo Health Expands Rare Disease Capabilities With Launch of SoleoRare™, A Specialty Pharmacy Focused on Complex Patient Needs

Soleo Health launches SoleoRare™, a dedicated rare disease specialty pharmacy delivering clinician-led, patient-centered care for rare disease patients.
April 14, 2026 02:00 ET | Source: PannTheraPi

PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique

PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique Le dépôt du dossier réglementaire pour l’initiation de l’essai clinique de Phase 2a évaluant son candidat...
April 14, 2026 02:00 ET | Source: PannTheraPi

PannTheraPi Announces Significant Clinical Development and Strategic Milestones

PannTheraPi files Phase 2a trial for epilepsy drug PTI5803, secures EU patent, and appoints Sophie Binay as GM & CSO.
April 13, 2026 10:29 ET | Source: Research and Markets

Small Molecule Innovator API CDMO Market Outlook, 2026-2033 - Lonza Group, Novo Holdings (Catalent) and Thermo Fisher Scientific Lead the Growing Industry

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type, Customer Type, Therapeutic Area, Region, and Segment...